Mass Polypeptide 2 Rescues Antigen Immunoproteasome Subunit Low Molecular Why the Structure but Not the Activity of the
暂无分享,去创建一个
Reinhold Weber | Michael Basler | Michael Przybylski | Christopher Tsu | Marcus Groettrup | Alexei F. Kisselev | Christoph Lauer | Jacqueline Moebius | M. Przybylski | A. Kisselev | M. Groettrup | Jacqueline Moebius | C. Tsu | C. Lauer | Michael Basler | Reinhold Weber
[1] P. Kloetzel,et al. The Interferon-γ-inducible 11 S Regulator (PA28) and the LMP2/LMP7 Subunits Govern the Peptide Production by the 20 S Proteasome in Vitro(*) , 1995, The Journal of Biological Chemistry.
[2] A. Goldberg,et al. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] Tomoki Chiba,et al. Immunoproteasome assembly and antigen presentation in mice lacking both PA28α and PA28β , 2001 .
[4] T. Soucy,et al. Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit , 2010, The Biochemical journal.
[5] K. Rajewsky,et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. , 1994, Science.
[6] K. Eichmann,et al. Expression of housekeeping and immunoproteasome subunit genes is differentially regulated in positively and negatively selecting thymic stroma subsets , 2004, European journal of immunology.
[7] P. Kloetzel,et al. Overexpression of the Proteasome Subunits LMP2, LMP7, and MECL-1, But Not PA28α/β, Enhances the Presentation of an Immunodominant Lymphocytic Choriomeningitis Virus T Cell Epitope1 , 2000, The Journal of Immunology.
[8] M. Groettrup,et al. An Altered T Cell Repertoire in MECL-1-Deficient Mice1 , 2006, The Journal of Immunology.
[9] M. van den Broek,et al. Immunoproteasomes are essential for survival and expansion of T cells in virus‐infected mice , 2010, European journal of immunology.
[10] S. Tonegawa,et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.
[11] M. Groettrup,et al. Proteasomes in immune cells: more than peptide producers? , 2010, Nature Reviews Immunology.
[12] J. Trowsdale,et al. Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. , 1999, Journal of immunology.
[13] B. Monsarrat,et al. Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation1 , 2006, The Journal of Immunology.
[14] L. Dick,et al. Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. , 1998, Bioorganic & medicinal chemistry letters.
[15] A. Henn,et al. Reduced Immunoproteasome Formation and Accumulation of Immunoproteasomal Precursors in the Brains of Lymphocytic Choriomeningitis Virus-Infected Mice , 2010, The Journal of Immunology.
[16] Lance F. Barton,et al. Regulation of Immunoproteasome Subunit Expression In Vivo Following Pathogenic Fungal Infection1 , 2002, The Journal of Immunology.
[17] M. Groettrup,et al. Immunoproteasome-specific inhibitors and their application. , 2012, Methods in molecular biology.
[18] C. Slaughter,et al. The Proteasome, a Novel Protease Regulated by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.
[19] P. Kloetzel,et al. Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes , 2000, The Journal of experimental medicine.
[20] R. Huber,et al. Structure of 20S proteasome from yeast at 2.4Å resolution , 1997, Nature.
[21] P. Kloetzel,et al. The proteasome regulator PA28α/β can enhance antigen presentation without affecting 20S proteasome subunit composition , 2000 .
[22] Marcus Groettrup,et al. Incorporation of major histocompatibility complex – encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon‐γ , 1995, European journal of immunology.
[23] Khalid W. Kalim,et al. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis , 2009, Nature Medicine.
[24] P. Kloetzel,et al. Inactivation of a Defined Active Site in the Mouse 20S Proteasome Complex Enhances Major Histocompatibility Complex Class I Antigen Presentation of a Murine Cytomegalovirus Protein , 1998, The Journal of experimental medicine.
[25] Peter M. Kloetzel,et al. MHC Class I Antigen Processing of an Adenovirus CTL Epitope Is Linked to the Levels of Immunoproteasomes in Infected Cells1 , 2000, The Journal of Immunology.
[26] B. Kessler,et al. A novel cytosolic class I antigen‐processing pathway for endoplasmic‐reticulum‐targeted proteins , 2007, EMBO reports.
[27] H. Overkleeft,et al. A cell-permeable inhibitor and activity-based probe for the caspase-like activity of the proteasome. , 2007, Bioorganic & medicinal chemistry letters.
[28] J. Shabanowitz,et al. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. , 1998, Journal of immunology.
[29] M. Probst-Kepper,et al. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. , 2000, Immunity.
[30] Keiji Tanaka,et al. Regulation of CD8+ T Cell Development by Thymus-Specific Proteasomes , 2007, Science.
[31] F. Sallusto,et al. Dendritic cells up‐regulate immunoproteasomes and the proteasome regulator PA28 during maturation , 1999, European journal of immunology.
[32] H. Rammensee,et al. Discrete Cleavage Motifs of Constitutive and Immunoproteasomes Revealed by Quantitative Analysis of Cleavage Products , 2001, The Journal of experimental medicine.
[33] A. Vitiello,et al. Impaired immunoproteasome assembly and immune responses in PA28-/- mice. , 1999, Science.
[34] D. Busch,et al. Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Kasahara,et al. Growth Retardation in Mice Lacking the Proteasome Activator PA28γ* , 1999, The Journal of Biological Chemistry.
[36] Ricarda Schwab,et al. Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity , 2012, Cell.
[37] Matthew Britton,et al. Selective inhibitor of proteasome's caspase-like sites sensitizes cells to specific inhibition of chymotrypsin-like sites. , 2009, Chemistry & biology.
[38] M. Groettrup,et al. No essential role for tripeptidyl peptidase II for the processing of LCMV‐derived T cell epitopes , 2007, European journal of immunology.
[39] Jonathan W. Yewdell,et al. Immunoproteasomes Shape Immunodominance Hierarchies of Antiviral Cd8+ T Cells at the Levels of T Cell Repertoire and Presentation of Viral Antigens , 2001, The Journal of experimental medicine.
[40] K. Schwarz,et al. Interferon-γ inducible exchanges of 20S proteasome active site subunits: Why? , 2001 .
[41] The Selective Proteasome Inhibitors Lactacystin and Epoxomicin Can Be Used to Either Up- or Down-Regulate Antigen Presentation at Nontoxic Doses1 , 2000, The Journal of Immunology.
[42] D. Valmori,et al. Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses. , 2006, Cancer research.
[43] Marcus Groettrup,et al. The Proteasome Inhibitor Bortezomib Enhances the Susceptibility to Viral Infection1 , 2009, The Journal of Immunology.
[44] K. Schwarz,et al. Immunoproteasomes Largely Replace Constitutive Proteasomes During an Antiviral and Antibacterial Immune Response in the Liver1 , 2001, The Journal of Immunology.
[45] M. Groettrup,et al. The Antiviral Immune Response in Mice Devoid of Immunoproteasome Activity , 2011, The Journal of Immunology.
[46] M. Groettrup,et al. Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome , 2010, The Journal of Immunology.
[47] V. Cerundolo,et al. Role of Immunoproteasomes in Cross-Presentation1 , 2006, The Journal of Immunology.
[48] Marcus Groettrup,et al. Immunoproteasomes Down-Regulate Presentation of a Subdominant T Cell Epitope from Lymphocytic Choriomeningitis Virus1 , 2004, The Journal of Immunology.